Medelan Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 22.65%
(FY 2022)
- Profit -55.41%
(FY 2022)
- Ebitda -348.18%
(FY 2022)
- Net Worth 5.24%
(FY 2022)
- Total Assets 59.11%
(FY 2022)
About Medelan Life Sciences
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Swati Sinha and Mukul Sinha serve as directors at the Company.
- CIN/LLPIN
U52100UP2017PTC097782
- Company No.
097782
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Medelan Life Sciences Private Limited offer?
Medelan Life Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Protein Powder, Ayurvedic,Herbal Products & Medicine, Ayurvedic Tablets, Medical Laboratory Instruments, VTM Kit Raw Materials, Ayurvedic Powder and Medicinal Herbs, Herbal Powder.
Who are the key members and board of directors at Medelan Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swati Sinha  | Director | 12-Oct-2017 | Current |
| Mukul Sinha | Director | 12-Oct-2017 | Current |
Financial Performance and Corporate Structure Insights of Medelan Life Sciences.
Medelan Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.65% increase. The company also saw a substantial fall in profitability, with a 55.41% decrease in profit. The company's net worth moved up by a moderate rise of 5.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medelan Life Sciences?
Unlock access to Medelan Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medelan Life Sciences?
Unlock and access historical data on people associated with Medelan Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medelan Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medelan Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
